slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 18,554
Current window 15,031-15,060
Pages 619
Rows per page 30
Component
15,031-15,060 of 18,554
258
The slide uses a Q&A format to highlight negative sentiment from a key opinion leader (KOL).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
260
The slide uses a Q&A format to validate the negative sentiment expressed in the summary header.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
262
The slide uses a Q&A format to validate the negative thesis regarding Wakix market performance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
263
The slide uses a Q&A format to highlight the tightening reimbursement environment for a specific drug.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
265
The slide uses a Q&A format to expose the physician's aggressive prescribing behavior and lack of clinical rigor.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
267
The slide uses highlighted text to emphasize aggressive prescribing behavior and high patient penetration rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
268
The slide uses highlighted text to emphasize the doctor's skepticism regarding the drug's 'game-changer' status and the saturation of his patient base.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
269
The slide uses highlighted text to emphasize the doctor's lack of due diligence and surprise at the drug's high cost.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
270
Includes verbatim Q&A excerpts highlighting patient volume and discontinuation rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
271
The slide uses highlighted text to emphasize negative feedback from a key opinion leader.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
272
The slide uses a Q&A format to expose negative feedback regarding drug interactions and side effects.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
274
The slide presents qualitative expert testimony regarding drug discontinuation rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
278
The slide uses a Q&A format to present qualitative feedback from a specific physician.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
281
The slide presents a transcript of an interview with a physician, highlighting negative clinical experience.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
282
The slide uses bolding and highlighting to emphasize negative sentiment from a key opinion leader.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
283
The slide uses a Q&A format to highlight a specific adverse event and the resulting loss of confidence in the drug's safety profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
284
The slide uses a Q&A format to document a specific adverse event case study.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
285
The slide uses a Q&A transcript format to detail a specific medical case study involving drug safety concerns.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
287
The slide uses a Q&A format to provide evidence for the summary points listed in the title.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
291
The slide uses a Q&A format to provide expert validation that scheduling is not a significant barrier to prescription.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
293
The slide uses highlighted text to emphasize key negative sentiments from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
297
The slide uses a 'preempt_rebuttal' or 'expose_contradiction' style to challenge the scientific validity of a drug's mechanism of action claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
298
The slide uses a 'fraud-exposure' approach by highlighting circular citations and methodological weaknesses in the foundational research.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
301
The slide uses a specific academic paper to undermine the scientific premise of a drug's mechanism of action.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
302
The slide uses box-whisker plots to demonstrate a lack of correlation between histamine/metabolite levels and various sleep disorder etiologies.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
303
The slide uses a direct excerpt from a scientific paper to undermine a previous scientific claim.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
304
The slide uses a direct quote from a scientific editorial to discredit a previously held hypothesis regarding pitolisant's mechanism of action.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
305
The slide uses underlined text to emphasize key findings that contradict the company's narrative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
307
The slide uses a combination of narrative argument and direct excerpts from regulatory documents to highlight a discrepancy in drug efficacy claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
308
The slide uses a strong accusatory tone, alleging fraudulent claims and intent to mislead the FDA.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit